Publications by authors named "Edouard Cubilier"
Article Synopsis
- Crohn's disease is primarily an inflammatory bowel disease that can lead to various complications, including immunoglobulin A nephropathy (IgAN), which affects kidney health.
- A case study highlights a young Crohn's patient who developed IgAN resulting in end-stage kidney disease and later discovered a rare and aggressive form of bladder cancer called urachal adenocarcinoma.
- The case emphasizes the necessity of thorough and continuous medical follow-up for Crohn's patients, stressing regular screenings and interdisciplinary care to catch complications early.
Article Synopsis
- - The process of assessing transplant suitability is complex, requiring multiple evaluations and specialist opinions, as outlined in the KDIGO guidelines, prompting a re-evaluation of their relevance in the context of evolving medical practices, especially in oncology.
- - The case study involves a 60-year-old woman with end-stage kidney disease stemming from prior rectal cancer treatment, leading to urological complications that complicate her kidney transplant options.
- - Key considerations for her transplant candidacy include the long-term absence of cancer recurrence and the frail state of her urological anatomy, requiring a careful balance of risks, benefits, and a patient-centered decision-making approach.
Infective endocarditis (IE) due to non-HACEK (species other than ) bacteremia accounts for less than 2% of all IE cases but is proven to be associated with higher mortality, even more so in hemodialysis (HD) patients. Few data are available in the literature concerning non-HACEK Gram-negative (GN) IE in this immunocompromised population with multiple comorbidities. We report the atypical clinical presentation of an elderly HD patient diagnosed with a non-HACEK GN IE, namely , successfully treated with intravenous (IV) antibiotics.
View Article and Find Full Text PDFCOVID-19 impact on an oncologic emergency department visits: observational study.
BMJ Support Palliat Care
February 2023
Objective: This study aimed at evaluating the impact of COVID-19 on emergency department (ED) visits in a tertiary cancer centre and providing information on the features of the unplanned events during the first wave of COVID-19 pandemic.
Methods: This retrospective observational study based on data from ED reports was divided into three periods of 2 months each around the first lockdown announcement of 17 March 2020: pre-lockdown, lockdown and post-lockdown.
Results: A total of 903 ED visits were included in the analyses.
Anuric hemodialyzed end-stage renal disease patients are prone to multiple complications and comorbidities and are therefore often treated with various medications. Adverse drug reactions and risk factors leading to them can be difficult to discern in such polymedicated patients. Most problems regarding low phosphate levels are frequently underdiagnosed in clinical practice and sometimes overlooked in these regularly hyperphosphatemic patients.
View Article and Find Full Text PDFPruritus is highly prevalent in the dialysis population. Its etiology however remains often unclear with uremic pruritus primarily suspected unless compelling evidence of another cause. Although bullous pemphigoid (BP) is considered idiopathic, there are growing data in the literature on BP provoked by different factors, such as medications or surgical procedures.
View Article and Find Full Text PDFForeign bodies such as implanted cardiac devices are susceptible to infections and may be involved in infective endocarditis. Exposure to pathogens, by frequent use of intravascular accesses for hemodialysis (i.e.
View Article and Find Full Text PDFBackground: Immunocompromised cancer patients are presumed to be at high risk of developing COVID-19 infection. Predisposing factors to contracting COVID-19 and to severe outcomes have been described in registries but were not compared between solid tumors and hematological malignancies.
Method: This retrospective single oncologic center study included adults with solid tumors or hematological malignancies referred to testing by naso-pharyngeal swab for a SARS-CoV-2 RT-PCR from March 10 to May 18, 2020.